MarginsXMarginsX
Home › Markets › Health Care › BTMD

Biote Corp. (BTMD)

BTMD trades on Nasdaq in Health Care, Medicinal Chemicals and Botanical Products . Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.9603
-9.83% on the day
Market cap
$34.5M
Nano cap
Revenue · 2025
$192.2M
-2.5% on 2024
Net income · 2025
$27.0M
14.1% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1819253/000119312526106099/0001193125-26-106099-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerBTMD on Nasdaq
SectorHealth Care
Industry Medicinal Chemicals and Botanical Products
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001819253
SEC industry codeMedicinal Chemicals & Botanical Products

Financials · 2025

LineValue
Revenue$192.2M
Net income$27.0M
Operating income$35.6M
Net margin14.1%
Operating margin18.5%
Revenue growth-2.5%
Cash$24.1M
Total assets$107.6M
P/E (computed)1.3×
P/S (computed)0.2×

Warning signs

Cash runway
Cash-flow positive
$8.9M cash at September 30, 2026
Share count, 1 year
-21.4%
2025-10-31 to 2026-11-04
Going-concern doubt
No
10-Q filed November 9, 2026
Insider net buying, 12 months
$202K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-09
Cash and burn$8.9M cash; operating cash flow $3.5M a quarter.Report 2026-09-30
Shares outstanding35,877,468 (2026-11-04); 45,662,630 a year earlier.Cover page 2026-11-04
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorDeloitte & Touche LLP, Dallas, Texas, United StatesPCAOB Form AP 2026-03-23
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $202K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$43.3M$407K$3.7M$8.9M$124.2M$178.9M10-Q 2026-11-09
Q2 2026
2026-06-30
$44.2M-$6.6M-$1.2M$11.2M$125.0M$183.5M10-Q 2026-08-07
Q1 2026
2026-03-31
$44.9M$2.3M$3.9M$5.3M$101.6M$188.2M10-Q 2026-05-11
Q4 2025
2025-12-31
$46.4M$2.0M$7.6M$24.1M$103.1M$192.2M10-K 2026-03-13
Q3 2025
2025-09-30
$48.0M$8.2M$14.1M$28.0M$104.7M$195.6M10-Q 2026-11-09
Q2 2025
2025-06-30
$48.9M$3.2M$7.1M$19.6M$106.3M$199.1M10-Q 2026-08-07
Q1 2025
2025-03-31
$49.0M$13.7M$6.5M$41.7M$107.8M$199.4M10-Q 2026-05-11
Q4 2024
2024-12-31
$49.8M$3.7M$12.4M$39.3M$109.4M$197.2M10-K 2026-03-13

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentPOS AM2025-04-09
Latest annual report10-K2026-03-13
Latest quarterly / interim10-Q2026-11-09
Latest current report8-K2026-11-04
Latest proxyDEFA14A2026-04-02

Source: SEC EDGAR submissions feed, 413 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+0.5%
1 month+2.4%
3 months-28.5%
Year to date-59.0%
1 year-59.0%
From 52-week high-62.6%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medicinal Chemicals and Botanical Products

TickerCompanyPriceDayMarket cap
FTLFFitLife Brands Inc.$6.83-19.46%$64.1M
ISPRIspire Technology Inc.$1.52-10.06%$87.8M
GLASGlass House Brands Inc. Subordinate Voting Shares$1.29+1.57%$113.5M
BONBon Natural Life Limited$1.09-0.91%$8.9M
NAGENiagen Bioscience Inc.$2.01-2.66%$159.2M
MTEXMannatech Incorporated$3.76-40.32%$7.3M
MDWDMediWound Ltd.$13.55+5.04%$195.0M
NAIINatural Alternatives International Inc.$0.9700+0.35%$6.1M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier